GAUSH MEDITECH (02407) has signed a five-year exclusive agency agreement with HEIDELBERG for the corneal confocal microscope T3.

GAUSH MEDITECH (02407) announced that its subsidiary, Gaoshi Innovation Technology Co., Ltd. (Gaoshi Innovation), recently signed a five-year exclusive agency agreement with HEIDELBERG ENGINEERING GmbH (HEIDELBERG) for the corneal confocal microscope T3, which was independently developed and manufactured by Gaoshi Innovation. According to this agreement, HEIDELBERG will exclusively represent and sell the related products worldwide, except in China, and will be responsible for market promotion and corresponding technical services. The corneal confocal microscope T3, independently developed and produced by Gaoshi Innovation, can observe the cornea and conjunctiva in vivo, assisting in the diagnosis of various corneal and conjunctival diseases: infectious diseases, non-infectious diseases, including corneal degeneration, keratitis, immune lesions, keratoconus, as well as surgery-related, traumatic, dry eye, and systemic disease-related corneal lesions, providing a basis for disease diagnosis and condition assessment. HEIDELBERG is a globally leading provider of ophthalmic diagnostic solutions headquartered in Germany. Since its establishment in 1998, the company has been the exclusive distributor of HEIDELBERG's ophthalmic imaging systems in China, making both parties important business partners.